NASDAQ NMS - GLOBAL MARKET · LITS
+3.06% · +$0.0303 · Vol Not reported
Pre-market · updated 04:00:09 ET
Lite Strategy Inc

Lite Strategy Inc

Biotechnology
$1.02
Card
Relationship Map

Veridion Score

BETALOW CONF · 4/6 factorsMethodology
Earnings absence reason unknown · Analyst data unavailable at compute time
LITS
Lite Strategy Inc
Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

48/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 4/6 factors with data · Fri Aug 21 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is LITS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading LITS catalysts
About Lite Strategy Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2003
Employees
4
Country
US

Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.9897
Last session
Day high
$0.9897
Last session
Day low
$0.9897
Last session
Previous close
$0.9897
52W high
$3.17
-67.82% from high
52W low
$0.7398
12% of range
Market cap
$33.7M
EPS
$-2.1333
Beta
1.13
Shares out
34M
Avg volume
142.1K
VWAP
$0.9897
Last session
Price history computed in-house
1W
+15.90%
1M
+3.20%
3M
-2.86%
YTD
-22.73%
SMA 50 $0.9321 · above
SMA 200 $1.21 · below
52W position 12%

LITS overview

Veridion Score
48
Registered · 2026-08-21
4 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around LITS.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading LITS Form 4 filings
Public disclosures

Congress activity in LITS

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for LITS in the cached public ledger.

Federal contracts

LITS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for LITS in this window.
Lobbying spend

LITS lobbying filings, year to date.

Registered lobbying filings matched to Lite Strategy Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for LITS in this window.
Loading news for LITS
Analyst ratings
Sovereign unlock shows live analyst consensus for LITS.
Options
Sovereign unlock shows live options positioning for LITS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.